This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
Pharmacyclics, Inc. (PCYC) is a pharmaceutical company developing products to improve upon current therapeutic approaches to cancer, atherosclerosis, and retinal disease. PCYC also gets an A in Equity. For more information, get Portfolio Grader’s complete analysis of PCYC stock.
Hilltop Holdings (HTH) provides business and consumer banking services in Texas. HTH also gets an A in Analyst Earnings Revisions. For more information, get Portfolio Grader’s complete analysis of HTH stock.
Insys Therapeutics, Inc. (INSY) develops pharmaceutical products that target the unmet needs of cancer patients, with a focus on cancer-supportive care. INSY also gets A’s in Analyst Earnings Revisions, Earnings Surprises and Equity. The price of INSY is up 50.4% since the first of the year. This is better than the Nasdaq, which has remained flat. For more information, get Portfolio Grader’s complete analysis of INSY stock.
China Recycling Energy (CREG) engages in the provision of energy savings and recycling products and services. CREG also gets A’s in Earnings Momentum and Cash Flow. For more information, get Portfolio Grader’s complete analysis of CREG stock.
Goldfield Corp. (GV) conducts electrical construction operations, including the placement of fiber optic cable and is also engaged in real estate operations. GV also gets an A in Equity. The stock has a trailing PE Ratio of 7.70. For more information, get Portfolio Grader’s complete analysis of GV stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.